Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Natural Immune Systems Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
EpiCor Clinical Study on Rapid Immune Modulating Effects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 19, 2023
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Natural Immune Systems Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Gastroenterology
Study Phase : Phase I/ Phase II
Sponsor : Hilton Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Saccharomyces Cerevisiae for Irritable Bowel Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
December 08, 2021
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I/ Phase II
Sponsor : Hilton Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Biofortis Mérieux Nutriscience
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Oral Probiotic Yeast on the Composition of the Vaginal Microbiota in Healthy Women
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 02, 2018
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Biofortis Mérieux Nutriscience
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Saccharomyces Cerevisiae in LDL Cholesterol
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
December 13, 2016
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Eurofins CDMO
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
January 26, 2015
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Eurofins CDMO
Deal Size : Inapplicable
Deal Type : Inapplicable